Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.28 - $2.23 $5,038 - $8,777
-3,936 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.85 - $4.59 $414 - $1,028
224 Added 6.03%
3,936 $8,000
Q4 2021

Feb 15, 2022

SELL
$2.33 - $5.74 $2,162 - $5,326
-928 Reduced 20.0%
3,712 $17,000
Q3 2021

Nov 15, 2021

SELL
$6.01 - $11.26 $44,269 - $82,941
-7,366 Reduced 61.35%
4,640 $28,000
Q2 2021

Aug 16, 2021

BUY
$10.12 - $17.46 $14,876 - $25,666
1,470 Added 13.95%
12,006 $135,000
Q4 2020

Feb 16, 2021

BUY
$15.38 - $32.42 $162,043 - $341,577
10,536 New
10,536 $256,000

Others Institutions Holding SPRB

About SPRUCE BIOSCIENCES, INC.


  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $9.19M
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.